{
  "claim_id": "claim_001",
  "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
  "document": {
    "pdf_name": "Liu_et_al.__2024_",
    "source_pdf": "data/clinical_files/Liu et al. (2024).pdf",
    "total_pages": 13,
    "total_blocks": 124,
    "total_characters": 39807
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 2,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "RIV4 contains 3 times the i d 45 HA/d / ...d",
      "relevance_explanation": "This quote directly states that RIV4 (Flublok Quadrivalent) contains 3 times the HA (hemagglutinin) antigen content compared to other vaccines, supporting the first part of the claim."
    },
    {
      "id": 2,
      "quote": "For A (H3 N2), RIV4 vaccination not only improved the quality of the functional neutralizing antibody ... it also significantly increased the quantity of the total A (H3 N2) cell HA head binding antibodies (Fig. 4 A, Fig. S1 A).",
      "relevance_explanation": "This quote provides evidence that RIV4 (Flublok) leads to a greater immunogenic response, specifically higher levels of functional and total HA antibodies, supporting the second part of the claim regarding greater immunogenicity versus standard-dose flu vaccines."
    }
  ],
  "model_used": "gpt-4.1"
}